Filter posts

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …

“High Tech Enables High Touch.” Stanford’s Dean of Medicine on How Technology is Changing the ...

Dean Lloyd Minor says technology, and specifically, smartphones are making healthcare deliverable in real-time. By …

100 Breakthrough Cancer Inventions from 100 Companies? BIO and CAI are Betting On It

There are more than 150,000 inventions that are “sitting on the shelf – because of …

New EDC Research Cracks the Code of the San Diego Genomics Industry

A news conference followed by a panel discussion with local experts today released the first …

A Patient Advocate Perspective on BIO

As the mother of a 12-year-old son with hypophosphatasia, the BIO International Convention is much …

The Sarcoma Foundation of America, a Patient Advocacy Group for a Rare Cancer

The Sarcoma Foundation of America (SFA) is national cancer research non-profit headquartered in Maryland.  Founded …

Taking on High-Risk Investments to Understand Brains and Solve Epilepsy

30 percent of people living with epilepsy do not have seizure control. Moreover, many can …

Why Shared Services Will Change Biopharma Forever

The mission statement for most biopharmaceutical companies is to bring lifesaving therapies to patients anywhere …